Sugi Predict

Sugi Predict / Compounds / SCHEMBL254353

SCHEMBL254353

SCHEMBL254353

CCOC(=O)C1(C(=O)OCC)CCCCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ OPRM1 P35372 4/20 0.38
▸ KDM4E B2RXH2 3/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ MGAM O43451 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ SI P14410 1/20 0.37
▸ MGAM2 Q2M2H8 1/20 0.37
▸ SOAT1 P35610 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ OPRD1 P41143 2/20 0.37
▸ OPRK1 P41145 2/20 0.37
▸ SLC22A1 O15245 1/20 0.37
▸ SLC6A4 P31645 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9806689 1.00 SMN1; SMN2 (0.41) SMN1; SMN2ALDH1A1MEN1KMT2APOLB
SCHEMBL1152835 0.98 SMN1; SMN2 (0.42) SMN1; SMN2ALDH1A1MEN1KMT2APOLB
SCHEMBL713102 0.93 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1MEN1KMT2APOLB
SCHEMBL22698674 0.92 NPSR1 (0.41) SMN1; SMN2ALDH1A1MEN1KMT2APOLB
Dioxane SCHEMBL6091078 0.90 TSHR (0.46) SMN1; SMN2ALDH1A1MEN1KMT2APOLB
SCHEMBL16847424 0.90 SMN1; SMN2 (0.36) SMN1; SMN2ALDH1A1MEN1KMT2APOLB
SCHEMBL10850510 0.90 SMN1; SMN2 (0.41) SMN1; SMN2ALDH1A1MEN1KMT2APOLB
SCHEMBL9806691 0.90 SMN1; SMN2 (0.41) SMN1; SMN2ALDH1A1MEN1KMT2APOLB
SCHEMBL20831146 0.90 NPSR1 (0.42) SMN1; SMN2ALDH1A1MEN1KMT2APOLB
SCHEMBL2321698 0.90 ALDH1A1 (0.39) SMN1; SMN2ALDH1A1MEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117380209-A Catalyst for phthalate hydrogenation and preparation method and application thereof 中国石油化工股份有限公司 2024-01-12 — — CN claimed
CN-109071806-B Crosslinked polymers, method for the production and use thereof 巴斯夫欧洲公司 2021-06-11 — — CN claimed
US-10800887-B2 Cross-linked polymers, methods for their manufacture, and use BASF SE (DE) 2020-10-13 — — US claimed
US-20190153167-A1 CROSS-LINKED POLYMERS, METHODS FOR THEIR MANUFACTURE, AND USE BASF SE (DE) 2019-05-23 — — US claimed
WO-2017194377-A1 CROSS-LINKED POLYMERS, METHODS FOR THEIR MANUFACTURE, AND USE BASF SE (DE) 2017-11-16 — — WO claimed
US-20240415847-A1 BETA-LACTAMASE INHIBITORS AND USES THEREOF ARIXA PHARMACEUTICALS, INC. (US) 2024-12-19 — — US disclosed
CN-118666671-A Lurasidone refining method of intermediate 江西金丰药业有限公司 2024-09-20 — — CN disclosed
EP-3860999-B9 DERIVATIVES OF RELEBACTAM AND USES THEREOF ARIXA PHARMACEUTICALS INC (US) 2024-08-14 — — EP disclosed
EP-3860999-B1 DERIVATIVES OF RELEBACTAM AND USES THEREOF ARIXA PHARMACEUTICALS INC (US) 2024-06-05 — — EP disclosed
CN-117425682-A Solid catalyst component for olefin polymerization, catalyst for olefin polymerization, process for producing olefin polymer, process for producing propylene block copolymer, and propylene block copolymer 东邦钛株式会社 2024-01-19 — — CN disclosed
CN-117380209-A Catalyst for phthalate hydrogenation and preparation method and application thereof 中国石油化工股份有限公司 2024-01-12 — — CN disclosed
EP-4303277-A1 ANTIFOULING COATING COMPOSITION Nitto Kasei Co., Ltd. (JP) 2024-01-10 — — EP disclosed
US-20040176425-A1 Cycloalkyl containing anilide ligands for the thyroid receptor BRISTOL-MYERS SQUIBB COMPANY 2004-09-09 — — US disclosed
WO-2004066929-A2 CYCLOALKYL CONTAINING ANILIDE LIGANDS FOR THE THYROID RECEPTOR BRISTOL-MYERS SQUIBB COMPANY (US) 2004-08-12 — — WO disclosed
US-20040054220-A1 Method for producing cyclohexane dicarboxylic acids and the derivatives thereof BASF AKTIENGESELLSCHAFT (DE) 2004-03-18 — — US disclosed
CN-1285815-A Process for hydrogenating benzenepolycarboxylic acids or derivatives thereof using catalysts containing macropores BASF AG (DE) 2001-02-28 — — CN disclosed
US-5412120-A Catalytic decarboxylation of corresponding geminal dicarboxylic acid BASF AKTIENGESELLSCHAFT (DE) 1995-05-02 — — US disclosed
US-5081131-A Omega-((hetero)alkyl)benz(cd)-indol-2-amines AMERICAN CYANAMID COMPANY (US) 1992-01-14 — — US disclosed
EP-0284005-B1 METHOD OF PRODUCTION OF POLYOLEFINS IDEMITSU PETROCHEMICAL CO. LTD. (JP) 1991-12-18 — — EP disclosed
EP-0230035-A2 Omega-[(hetero)alkyl]benz[cd]indol-2-amines AMERICAN CYANAMID COMPANY (US) 1987-07-29 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040176425-A1 Cycloalkyl containing anilide ligands for the thyroid receptor TSHR, THRB, TRHR SMN1; SMN2 4835/4885ALDH1A1 1691/4885MEN1 3912/4885
US-20040054220-A1 Method for producing cyclohexane dicarboxylic acids and the derivatives thereof HPD, HCAR2, ACMSD SMN1; SMN2 4670/4885ALDH1A1 503/4885MEN1 321/4885
US-20240415847-A1 BETA-LACTAMASE INHIBITORS AND USES THEREOF GAA, LCT, MGAM SMN1; SMN2 3557/4885ALDH1A1 830/4885MEN1 3937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.